Latest filings (excl ownership)
REVOKED
Registration or securities revoked
9 Apr 19
NT 10-Q
Notice of late quarterly filing
15 Nov 16
NT 10-Q
Notice of late quarterly filing
15 Aug 16
NT 10-Q
Notice of late quarterly filing
16 May 16
8-K/A
Changes in Registrant's Certifying Accountant
28 Apr 16
8-K
Changes in Registrant's Certifying Accountant
6 Apr 16
25-NSE
Exchange delisting
23 Feb 16
8-K
Skystar Bio-pharmaceutical Company Announces Delisting from Nasdaq
18 Dec 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Notification Letter
20 Nov 15
NT 10-Q
Notice of late quarterly filing
16 Nov 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Notification Letter
23 Oct 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Non-compliance Letter Due to Delay In Filing Form 10-Q
25 Aug 15
NT 10-Q
Notice of late quarterly filing
14 Aug 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Non-compliance Letter Due to Delay In Filing Form 10-Q
22 May 15
NT 10-Q
Notice of late quarterly filing
18 May 15
8-K
Skystar Bio-pharmaceutical Company Announces Receipt of Nasdaq Non-compliance Letter Due to Delay In Filing Form 10-K
15 Apr 15
NT 10-K
Notice of late annual filing
1 Apr 15
8-K
Submission of Matters to a Vote of Security Holders
5 Dec 14
10-Q
2014 Q3
Quarterly report
14 Nov 14
DEF 14A
Definitive proxy
14 Nov 14
10-Q
2014 Q2
Quarterly report
14 Aug 14
8-K
Material Modifications to Rights of Security Holders
21 Jul 14
424B5
Prospectus supplement for primary offering
16 Jul 14
8-K
Entry into a Material Definitive Agreement
16 Jul 14
10-Q
2014 Q1
Quarterly report
15 May 14
8-K
Other Events
16 Apr 14
10-K
2013 FY
Annual report
31 Mar 14
8-K
Entry into a Material Definitive Agreement
13 Mar 14
EFFECT
Notice of effectiveness
18 Dec 13
S-3/A
Shelf registration (amended)
16 Dec 13
S-3
Shelf registration
4 Dec 13
10-Q
2013 Q3
Quarterly report
14 Nov 13
8-K
Submission of Matters to a Vote of Security Holders
30 Oct 13
DEF 14A
Definitive proxy
27 Sep 13
10-Q
2013 Q2
Quarterly report
14 Aug 13
10-Q
2013 Q1
Quarterly report
15 May 13
10-K
2012 FY
Annual report
1 Apr 13
10-Q
2012 Q3
Quarterly report
14 Nov 12
8-K
Submission of Matters to a Vote of Security Holders
26 Oct 12
DEF 14A
Definitive proxy
21 Sep 12
Latest ownership filings
SC 13G/A
Skystar Bio-pharmaceutical Co
11 Jan 16
SC 13D/A
Skystar Bio-pharmaceutical Co
2 Jun 15
4
JOHN M GREGORY
28 May 15
4
JOHN M GREGORY
7 May 15
4
JOHN M GREGORY
20 Apr 15
SC 13D/A
Skystar Bio-pharmaceutical Co
4 Feb 15
SC 13G/A
Skystar Bio-pharmaceutical Co
12 Jan 15
SC 13D/A
Skystar Bio-pharmaceutical Co
15 Dec 14
SC 13G
Skystar Bio-pharmaceutical Co
17 Jul 14
SC 13D/A
Skystar Bio-pharmaceutical Co
28 May 14
SC 13D/A
Skystar Bio-pharmaceutical Co
15 Apr 14
SC 13D/A
Skystar Bio-pharmaceutical Co
2 Apr 14
SC 13D
Skystar Bio-pharmaceutical Co
24 Mar 14
SC 13G/A
Skystar Bio-pharmaceutical Co
24 Sep 13
SC 13G/A
Skystar Bio-pharmaceutical Co
23 Sep 13
SC 13G/A
Skystar Bio-pharmaceutical Co
13 Sep 13
SC 13G/A
Skystar Bio-pharmaceutical Co
4 Sep 13
SC 13G/A
Skystar Bio-pharmaceutical Co
22 Aug 13